BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17429563)

  • 1. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.
    Sippel RS; Caron NR; Clark OH
    World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.
    Navas-Carrillo D; Ríos A; Rodríguez JM; Parrilla P; Orenes-Piñero E
    Biochim Biophys Acta; 2014 Dec; 1846(2):468-76. PubMed ID: 25218916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
    Moses W; Weng J; Kebebew E
    Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.
    Hillenbrand A; Varhaug JE; Brauckhoff M; Pandev R; Haufe S; Dotzenrath C; Köberle R; Hoffmann R; Klein G; Kadmon M; Negele T; Hagieva T; Henne-Bruns D; Luster M; Weber T
    Langenbecks Arch Surg; 2010 Sep; 395(7):851-8. PubMed ID: 20683623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
    Vriens MR; Suh I; Moses W; Kebebew E
    Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and biological features of familial nonmedullary thyroid carcinoma].
    Gao J; Yu Y; Li X; Zhao J; Zhao C; Zhao J; Liu Y; Li Y; Gao M
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):202-6. PubMed ID: 24785281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial nonmedullary thyroid cancer.
    Sturgeon C; Clark OH
    Thyroid; 2005 Jun; 15(6):588-93. PubMed ID: 16029126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
    Bauer AJ
    Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.
    Park YJ; Ahn HY; Choi HS; Kim KW; Park DJ; Cho BY
    Thyroid; 2012 Apr; 22(4):356-62. PubMed ID: 22280228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
    Robenshtok E; Tzvetov G; Grozinsky-Glasberg S; Shraga-Slutzky I; Weinstein R; Lazar L; Serov S; Singer J; Hirsch D; Shimon I; Benbassat C
    Thyroid; 2011 Jan; 21(1):43-8. PubMed ID: 20954815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on familial nonmedullary thyroid cancer.
    Ammar SA; Alobuia WM; Kebebew E
    Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial nonmedullary thyroid cancer: a review of the genetics.
    Khan A; Smellie J; Nutting C; Harrington K; Newbold K
    Thyroid; 2010 Jul; 20(7):795-801. PubMed ID: 20465534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial non-medullary thyroid cancer: a matched-case control study.
    Maxwell EL; Hall FT; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma.
    Uchino S; Noguchi S; Yamashita H; Murakami T; Watanabe S; Ogawa T; Tsuno A; Shuto S
    World J Surg; 2004 Nov; 28(11):1099-102. PubMed ID: 15490050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial nonmedullary thyroid carcinoma.
    Mazeh H; Sippel RS
    Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer.
    Vriens MR; Sabanci U; Epstein HD; Ngai S; Duh QY; Siperstein AE; Clark OH
    Thyroid; 1999 Oct; 9(10):1011-6. PubMed ID: 10560956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
    Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
    J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
    Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS
    Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
    Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
    Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.